Oncomine Tumor Mutation Burden (TMB)
The Oncomine TMB test measures the total number of mutations in a tumor’s DNA. A high TMB is associated with a better response to certain immunotherapies in cancer treatment.
Overview of Oncomine Tumor Mutation Burden (TMB) in Kannur
The Oncomine Tumor Mutation Burden (TMB) Test is an advanced molecular test that measures the number of genetic mutations present within a tumor. Tumor Mutation Burden is an important genomic biomarker that can provide insights into the biological characteristics of cancer and may help identify patients who could benefit from certain immunotherapy treatments. Using next-generation sequencing (NGS) technology, the test evaluates multiple genes simultaneously to generate a comprehensive mutation profile, supporting a more personalized approach to cancer care.
Who Should Get This Test Done?
This test may be recommended for individuals who:
● Have been diagnosed with advanced or metastatic solid tumors.
● Are being evaluated for immunotherapy as a treatment option.
● Require comprehensive molecular profiling of their tumor.
● Have recurrent cancer and need additional information to guide treatment decisions.
● Are advised by an oncologist to undergo genomic testing as part of precision oncology.
Why Consider This Test?
Cancer treatment is becoming increasingly personalized, and understanding the genetic makeup of a tumor can make a significant difference in treatment planning. The Oncomine Tumor Mutation Burden Test helps estimate the overall number of mutations within a tumor, providing valuable information that may support decisions regarding immunotherapy and other targeted treatment strategies. When combined with clinical findings and other molecular biomarkers, it enables healthcare providers to develop a treatment plan tailored to the unique characteristics of the patient’s cancer.
More Information
The Oncomine Tumor Mutation Burden Test is performed on tumor tissue using advanced next-generation sequencing technology. In addition to assessing tumor mutation burden, the generated molecular data may contribute to a broader understanding of the tumor’s genomic profile. The results are interpreted alongside histopathology, clinical history, imaging findings, and other biomarker tests to support comprehensive cancer evaluation and individualized treatment planning.
Other Names
● TMB Test
● Tumor Mutation Burden Assessment
● Oncomine TMB Assay
● Somatic Mutation Burden Test
● Cancer Mutation Load Test
● TMB-NGS Panel
● Tumor Mutational Load Test
● Oncomine Mutation Load Assay
● Solid Tumour TMB Panel
Test included
- Oncomine Tumor Mutation Burden (tmb)
Doctor information
Test code
G550
CPT and Loinc codes
Department
- Advanced Molecular Diagnostics R&d
Turn around time
28 Working Days
Test run frequency
Every Day TIME - 08:00
Performing locations
1 labs across India
Specimen vol. and vacutainer information
| Specimen | Vacutainer | Volume |
|---|---|---|
| Tissue | Others | 3 ML |
Specimen stability information
Tissue
Collection instructions
Age,Gender,Clinical history required
Test price
₹37125
Need Help?
Talk to our health experts for guidance on tests, reports, or bookings.
WhatsApp to Book TestOncomine Tumor Mutation Burden (TMB)
₹37125